Measles
📧 Sign up to get email alerts when something new happens for Measles.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR [Phase 4]
Phase 4 trial assessing whether the measles-mumps-rubella vaccine virus is excreted in breast milk after postpartum vaccination; the study s…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months [NA]
A completed trial assessing whether supplementation with SQ-LNS incentives can boost measles vaccination coverage in children aged 6-23 mont…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age [Phase 3]
This Phase 3 clinical trial evaluates the immune response and safety of an investigational combined measles, mumps, rubella and varicella va…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age [Phase 4]
A Phase 4 trial assessing how limiting measles vaccination to children under 12 months affected overall mortality in a national program.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial of Additional Measles Vaccine to Reduce Child Mortality [Phase 4]
A Phase 4 clinical trial assessing whether an additional measles vaccine dose can reduce child mortality has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso. [Phase 4]
Phase 4 clinical trial in Burkina Faso evaluating an additional measles vaccine to reduce child mortality has completed.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Predictors of Measles Vaccine Hesitancy in New York State
This completed clinical trial examined predictors of measles vaccine hesitancy in New York, identifying factors associated with reluctance t…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
An ongoing recruitment update for a One Health study evaluating the risk of community spread of multiple endemic infectious diseases. The st…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
Clinical trial update for VALID evaluating antibody responses to the measles vaccine in children with Sickle Cell Disease. The study is curr…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
This clinical trial update examines five-year antibody persistence after vaccination with IPV, MMR, and HepA-L vaccines. The study is not ye…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months [Phase 3]
Phase 3 trial comparing SIBP's Measles-Mumps-Rubella vaccine with GlaxoSmithKline's MMR vaccine in children aged 9-11 months has completed.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron Deficiency [NA]
The study investigates whether iron treatment in Kenyan infants with iron deficiency influences malaria outcomes and the response to measles…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Unravelling the Measles Paradox (MISIA)
Erasmus Medical Center has a recruiting clinical trial (MISIA) focused on studying aspects of measles disease.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Unravelling the Measles Paradox in Children
A registered pediatric trial from Erasmus Medical Center aims to study the measles paradox in children; recruitment has not yet begun.
-
EMA approval · 2025-10-30EMA Authorised: M-M-RVaxPro (measles virus Enders’ Edmonston strain (live, attenuated);mumps virus Jeryl Lynn (level B) strain (live, attenuated);rubella virus Wistar RA 27/3 strain (live, attenuated)) — Merck Sharp & Dohme B.V.
The EMA authorised Merck's M-M-RVaxPro, a live attenuated measles‑mumps‑rubella vaccine, for immunization against measles, mumps and rubella…
-
EMA approval · 2025-09-25EMA Authorised: ProQuad (virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella) — Merck Sharp & Dohme B.V.
EMA has authorized ProQuad, a live attenuated vaccine that protects against varicella (chickenpox), measles, mumps and rubella in the Europe…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) [Phase 4]
Phase 4 trial evaluating immunogenicity when a Japanese encephalitis vaccine is co-administered with a Measles-Mumps-Rubella vaccine; the st…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections
A prospective clinical registry evaluating exanthematous infections and coinfections, including dengue fever, chikungunya, measles, and rube…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Measles Vaccination at Health System Contacts [Phase 4]
A Phase 4 clinical trial update on measles vaccination delivered at health-system contacts, currently enrolling by invitation to evaluate ho…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age [Phase 4]
A Phase 4 CDC-sponsored study assessed the immunogenicity of the Measles-Rubella vaccine in infants at 6 and 9 months, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age [Phase 2]
Phase 2 trial comparing immune response and safety of a combined measles, mumps, rubella, and varicella vaccine against a marketed MMRV vacc…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Investigation of Immune Amnesia Following Measles Infection in Select African Regions
This clinical trial update reports an investigation into immune amnesia following measles infection in select African regions. The study is …
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal
This update describes the planned clinical evaluation of a measles rapid diagnostic test in Senegal, with the study currently not recruiting…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Barriers and Facilitators to MMR Vaccination Among Healthcare Workers
This completed clinical trial examines barriers and facilitators to MMR vaccination among healthcare workers. The study focuses on preventin…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Study of Concomitant Administration of the sIPV and DTaP or MMR [Phase 4]
Phase 4 trial evaluating concomitant administration of Sabin inactivated polio vaccine (sIPV) with DTaP or MMR vaccines; sponsored by the In…